GGPPS deficiency aggravates CCl4-induced liver injury by inducing hepatocyte apoptosis

FEBS Lett. 2015 Apr 28;589(10):1119-26. doi: 10.1016/j.febslet.2015.03.015. Epub 2015 Mar 24.

Abstract

GGPPS catalyses the expression of GGPP, a key protein in the mevalonate metabolic pathway. HMG-CoA reductase inhibitor statins can induce liver injury by inhibiting GGPP. However, the function of GGPPS in liver injury has not yet been revealed. In this study, we found that GGPPS increased in liver injury and that GGPPS deletion augmented liver injury and fibrosis. GGPPS inhibition induced hepatocyte apoptosis, inflammation and TGF-β1 secretion, which activated hepatic stellate cells. Our findings imply that GGPPS deletion induces hepatocyte apoptosis, which makes the liver vulnerable to hepatotoxicity.

Keywords: Geranylgeranyl diphosphate synthase; Hepatocyte apoptosis; Liver fibrosis; Liver injury.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Carbon Tetrachloride Poisoning / enzymology*
  • Carbon Tetrachloride Poisoning / genetics
  • Carbon Tetrachloride Poisoning / pathology
  • Farnesyltranstransferase / genetics
  • Farnesyltranstransferase / metabolism*
  • Gene Deletion
  • Hepatocytes / enzymology*
  • Hepatocytes / pathology
  • Liver / enzymology*
  • Liver / pathology
  • Liver Cirrhosis / chemically induced
  • Liver Cirrhosis / enzymology*
  • Liver Cirrhosis / genetics
  • Liver Cirrhosis / pathology
  • Mice
  • Mice, Knockout
  • Polyisoprenyl Phosphates / biosynthesis
  • Transforming Growth Factor beta1 / genetics
  • Transforming Growth Factor beta1 / metabolism

Substances

  • Polyisoprenyl Phosphates
  • Tgfb1 protein, mouse
  • Transforming Growth Factor beta1
  • Farnesyltranstransferase
  • geranylgeranyl pyrophosphate